Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare ...

Doubled the royalty and milestone portfolio to over 120 royalty assets with significant milestone potential through five ...